State Street Corporation 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 11:47 am Purchase | 2022-12-31 | 13G | G1 Therapeutics, Inc. GTHX | STATE STREET CORP STT | 179,736 0.360% | 37,530 (+26.39%) | Filing |
| 2022-07-11 1:20 pm Sale | 2022-06-30 | 13G | G1 Therapeutics, Inc. GTHX | STATE STREET CORP STT | 142,206 0.330% | -4,159,407 (-96.69%) | Filing |
| 2022-02-11 08:12 am Sale | 2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX | STATE STREET CORP STT | 4,301,613 10.120% | -81,999 (-1.87%) | Filing |
| 2021-10-12 12:30 pm Purchase | 2021-09-30 | 13G | G1 Therapeutics, Inc. GTHX | STATE STREET CORP STT | 4,383,612 10.350% | 1,803,793 (+69.92%) | Filing |
| 2021-02-11 1:07 pm Purchase | 2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX | STATE STREET CORP STT | 2,579,819 6.780% | 2,579,819 (New Position) | Filing |